Stockscreener 앱 받기
30.40
1.59%
-0.49
시장 영업 전:
30.70
0.30
+0.99%
Metsera Inc 주식(MTSR)의 최신 뉴스
Metsera Inc (MTSR) Six Month Summary: The Bright Spot in a Quiet Biotech Year - Smartkarma
Metsera, Inc. Reports Q2 2025 Financial Progress - The Globe and Mail
Watch for Bullish Crossover in Metsera Inc.Quick Gain Stock Watch With Indicators Reviewed - metal.it
What is Metsera Inc. company’s growth strategyPhenomenal trading returns - Jammu Links News
What are the latest earnings results for Metsera Inc.Unlock your portfolio’s hidden potential - Jammu Links News
Why is Metsera Inc. stock attracting strong analyst attentionUnlock expert insights for smarter investing - Jammu Links News
How volatile is Metsera Inc. stock compared to the marketBuild a diversified portfolio for risk mitigation - Jammu Links News
Is it the right time to buy Metsera Inc. stockFree Stock Market Beginners Guide - Jammu Links News
What are Metsera Inc. company’s key revenue driversUnlock powerful trading techniques - Jammu Links News
What are analysts’ price targets for Metsera Inc. in the next 12 monthsBreakthrough financial growth - Jammu Links News
What catalysts could drive Metsera Inc. stock higher in 2025Get timely alerts on market opportunities - Jammu Links News
Is Metsera Inc. a growth stock or a value stockGet exclusive market analysis for investors - Jammu Links News
How strong is Metsera Inc. company’s balance sheetBuild wealth with high-performing stocks - Jammu Links News
We're Hopeful That Metsera (NASDAQ:MTSR) Will Use Its Cash Wisely - Yahoo Finance
Metsera Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingDay Trading Signals With High Precision Reviewed - metal.it
Metsera, Inc. Lock-Up Agreement Expiration: 30-JUL-2025 - AInvest
Metsera stock rating reiterated by Cantor Fitzgerald ahead of key updates - Investing.com Nigeria
Guggenheim Maintains Metsera(MTSR.US) With Buy Rating, Maintains Target Price $62 - 富途牛牛
Metsera, Inc. Poised for Growth: Anticipated Catalysts and Clinical Trial Success Drive Buy Rating - TipRanks
What makes Metsera Inc. stock price move sharplyBuy Low Sell High Stock Watch Strategy in Focus - metal.it
Metsera reports Q2 EPS (66c), consensus (68c) - TipRanks
Metsera, Inc.: Why Shares Are on the Rise - TipRanks
Metsera Posts Narrower Q2 Loss - MarketScreener
Metsera shares tumble as quarterly loss worse than expected By Investing.com - Investing.com Canada
Metsera shares tumble as quarterly loss worse than expected - Investing.com
Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress - GlobeNewswire
Metsera Obesity Drug Achieves 8.4% Weight Loss in 5 Weeks; Multiple Trial Results Coming in 2025 - Stock Titan
Recent Price Trend in Metsera Inc. (MTSR) is Your Friend, Here's Why - Yahoo Finance
Chartists Watching For Breakout in Metsera Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it
Should I hold or sell Metsera Inc. stock in 2025Stock Market Review That Work - jammulinksnews.com
What is the dividend policy of Metsera Inc. stockExpert guidance for superior capital growth - Jammu Links News
Does Metsera Inc. stock perform well during market downturnsUnmatched market performance - jammulinksnews.com
What institutional investors are buying Metsera Inc. stockCapitalize on high-yield stock opportunities - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):